免疫表型影响严重皮肤不良反应的管理
1Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Current opinion in allergy and clinical immunology
|June 12, 2025
概括
严重的皮肤不良反应 (SCARs),包括史蒂文斯-约翰逊综合征 (SJS) /有毒表皮解 (TEN) 和药物诱导的过敏综合征/带有异敏性和全身症状的药物反应 (DIHS/DRESS),已经确定了关键途径和潜在的治疗方法. 为了有效管理SCAR,需要进一步的研究.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 药物基因组学 药物基因组学
- 药物过敏症 药物过敏症
背景情况:
- 严重的皮肤不良反应 (SCARs) 包括史蒂文斯-约翰逊综合征 (SJS) /有毒表皮解 (TEN) 和药物诱导的过敏综合征/带有异敏性和全身症状的药物反应 (DIHS/DRESS).
- 了解SCARs的发病机理对于开发有效的治疗方法至关重要.
研究的目的:
- 审查了解SCARs病理机制的最新进展.
- 提供有关SCARs患者管理的见解.
主要方法:
- 审查最近的研究,包括单细胞数据分析.
- 确定关键信号通路和参与SCAR病变的免疫表型.
主要成果:
- 已经确定了SCAR中的关键信号通路和免疫表型.
- 已经突出了潜在的治疗点,如TNF-α和JAK抑制剂.
- 现在可以获得DIHS/DRESS的严重性评分和生物标志物.
结论:
- 虽然SCAR的发病因子尚未完全阐明,但SJS/TEN中的角质细胞死亡得到了更好的理解.
- 建议在DIHS/DRESS的早期和晚期阶段有不同的免疫特征.
- 新的治疗方案需要进一步的临床试验数据来验证和开发一般治疗策略.
相关概念视频
Hypersensitivities
550
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
550
Allergic Drug Reactions
818
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
818
Allergic Reactions
27.3K
Overview
27.3K
Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
245
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
245
Cell-mediated Immune Responses
67.8K
Overview
67.8K


